Who are the key players in the Vectibix (panitumumab) Market Report 2026 market?

Major companies operating in the Vectibix (panitumumab) Market Report 2026 market are Major companies operating in the vectibix (panitumumab) market are Amgen Inc. Read More

What are the major opportunities in the Vectibix (panitumumab) market? What are the strategies for the Vectibix (panitumumab) market?

For detailed insights on the major opportunities and strategies in the Vectibix (panitumumab) market, Read More

How does the Vectibix (panitumumab) market relate to the overall economy and other similar markets?

For detailed insights on Vectibix (panitumumab)'s relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Vectibix (panitumumab) industry?

For detailed insights on the mergers and acquisitions in the Vectibix (panitumumab) industry, Read More

What are the key dynamics influencing the Vectibix (panitumumab) market growth? SWOT analysis of the Vectibix (panitumumab) market.

For detailed insights on the key dynamics influencing the Vectibix (panitumumab) market growth and SWOT analysis of the Vectibix (panitumumab) industry, Read More

Vectibix (panitumumab) Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Vectibix (panitumumab) Market Report 2026

Name: Vectibix (panitumumab) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Vectibix (panitumumab) Market Overview

• The Vectibix (panitumumab) market growth in the historic period has been driven by approval for metastatic colorectal cancer, proven egfr inhibition efficacy

• Market expansion is supported by growth in precision medicine adoption, increasing cancer diagnostics

• Growth Driver: Rising Prevalence Of Colorectal Cancer To Drive Growth Of Vectibix (Panitumumab) Market

• Market Trend: Advancements In Molecular Diagnostics With Companion Diagnostic Kits Enhancing Personalized Treatment In The Vectibix (Panitumumab) Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vectibix (panitumumab) Market?

Vectibix (panitumumab) is a monoclonal antibody used in cancer treatment, specifically for metastatic colorectal cancer (mCRC). It works by targeting the epidermal growth factor receptor (EGFR), which is a protein found on the surface of some cancer cells. Panitumumab binds to EGFR and prevents the receptor from being activated by natural growth factors, thus inhibiting the signaling pathways that promote cell division and tumor growth.

The main types of vectibix (panitumumab) distribution channels include hospital pharmacies and online pharmacies. Hospital pharmacies are pharmacies located within hospitals or healthcare facilities that provide medications to inpatients and outpatients as part of integrated medical care. It is used for colorectal cancer treatment and other cancer treatments by various end-users, including hospitals, clinics, and ambulatory surgical centers.

Vectibix (panitumumab) Market Global Report 2026 Market Report bar graph

What Is The Vectibix (panitumumab) Market Size and Share 2026?

The vectibix (panitumumab) market size has grown strongly in recent years. It will grow from $1.37 million in 2025 to $1.48 million in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to approval for metastatic colorectal cancer, proven egfr inhibition efficacy, oncology specialist adoption, rising colorectal cancer incidence, advancement in targeted cancer drugs.

What Is The Vectibix (panitumumab) Market Growth Forecast?

The vectibix (panitumumab) market size is expected to see strong growth in the next few years. It will grow to $2 million in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growth in precision medicine adoption, increasing cancer diagnostics, expansion into additional cancer therapies, rising oncology healthcare spending, improved patient stratification. Major trends in the forecast period include increased use of targeted egfr therapies, expansion of precision oncology treatments, rising biomarker based patient selection, hospital based monoclonal antibody adoption, combination therapy use in advanced cancers.

Book your 30 minutes free consultation with our research experts

Global Vectibix (panitumumab) Market Segmentation

1) By Distribution Channel: Hospital Pharmacies, Online Pharmacies

2) By Application: Colorectal Cancer Treatment, Other Cancer Treatments

3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers

What Are The Drivers Of The Vectibix (panitumumab) Market?

The increasing prevalence of colorectal cancer is expected to propel the growth of the vectibix (panitumumab) market going forward. Colorectal cancer refers to a type of cancer that starts in the colon or rectum, often developing from precancerous polyps. The rising prevalence of colorectal cancer is due to unhealthy lifestyle habits, as poor diet, lack of exercise, and obesity increase the risk of polyp formation and cancer development. Vectibix (panitumumab) is a monoclonal antibody that targets and inhibits the epidermal growth factor receptor (EGFR), which helps slow tumor growth and progression in patients with wild-type KRAS tumors, thus offering an effective therapeutic option for those who have not responded to conventional chemotherapy treatments. For instance, in February 2025, according to the American Cancer Society, a US-based nonprofit organization, the estimated number of new colorectal cancer cases was 154,270, an increase from 152,810 cases in 2024. Therefore, the increasing prevalence of colorectal cancer is expected to propel the growth of the vectibix (panitumumab) industry.

The rising demand for personalized medicine is expected to propel the growth of the vectibix (panitumumab) market going forward. Personalized medicine is an approach to healthcare that customizes treatments and strategies based on the unique characteristics, needs, and preferences of each patient. The rising personalized medicine is due to due to advancements in genomic technologies, which enable the precise identification of genetic variations and tailored treatments for individuals. Vectibix (panitumumab) is used for personalized medicine by targeting the epidermal growth factor receptor (EGFR) on cancer cells, enabling tailored treatment for patients with metastatic colorectal cancer whose tumors express wild-type EGFR, thereby optimizing therapeutic efficacy and minimizing unnecessary side effects based on individual genetic profiles. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the rising demand for personalized medicine is driving th e growth of the vectibix (panitumumab) industry.

Key Players In The Global Vectibix (panitumumab) Market

Major companies operating in the vectibix (panitumumab) market are Amgen Inc.

Global Vectibix (panitumumab) Market Trends and Insights

Major companies operating in the vectibix (panitumumab) market are focusing on developing advanced companion diagnostics to enable targeted therapies, improve treatment efficacy, and ensure patient safety. Companion diagnostics refer to tests that provide essential information for the safe and effective use of a corresponding therapeutic product. For instance, in October 2023, EntroGen Inc., a US-based biotechnology company, received the U.S. Food and Drug Administration (FDA) approval for the CRCdx RAS Mutation Detection Kit as a companion diagnostic for Vectibix (panitumumab). The CRCdx RAS mutation detection kit is a unique molecular diagnostic tool that represents a significant advancement in precision medicine for colorectal cancer (CRC) patients. It is the first real-time PCR-based test in the U.S. to receive premarket approval (PMA) and fully meet the biomarker identification requirement for Vectibix. This innovative kit is designed to accurately detect mutations in KRAS and NRAS exons 2, 3, and 4, offering high sensitivity and specificity. It enables clinicians to efficiently identify patients most likely to benefit from vectibix therapy, minimizing unnecessary side effects and treatment costs.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the vectibix (panitumumab) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Vectibix (panitumumab) Market?

The vectibix (panitumumab) market consists of sales of chemotherapy combination products, nutritional supplements, supportive care medications and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vectibix (panitumumab) Market Report 2026?

The vectibix (panitumumab) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vectibix (panitumumab) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Vectibix (panitumumab) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	CAGR of 8.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Distribution Channel, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Amgen Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Vectibix (panitumumab) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Vectibix (panitumumab) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Vectibix (panitumumab) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Vectibix (panitumumab) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increased Use Of Targeted Egfr Therapies

4.2.2 Expansion Of Precision Oncology Treatments

4.2.3 Rising Biomarker Based Patient Selection

4.2.4 Hospital Based Monoclonal Antibody Adoption

4.2.5 Combination Therapy Use In Advanced Cancers

5. Vectibix (panitumumab) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Clinics

5.3 Cancer Treatment Centers

5.4 Academic Medical Centers

5.5 Specialty Care Centers

6. Vectibix (panitumumab) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Vectibix (panitumumab) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Vectibix (panitumumab) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Vectibix (panitumumab) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Vectibix (panitumumab) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Vectibix (panitumumab) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Vectibix (panitumumab) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Vectibix (panitumumab) Market Segmentation

9.1. Global Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Online Pharmacies

9.2. Global Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Colorectal Cancer Treatment, Other Cancer Treatments

9.3. Global Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Ambulatory Surgical Centers

10. Vectibix (panitumumab) Market Regional And Country Analysis

10.1. Global Vectibix (panitumumab) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Vectibix (panitumumab) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Vectibix (panitumumab) Market

11.1. Asia-Pacific Vectibix (panitumumab) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Vectibix (panitumumab) Market

12.1. China Vectibix (panitumumab) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Vectibix (panitumumab) Market

13.1. India Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Vectibix (panitumumab) Market

14.1. Japan Vectibix (panitumumab) Market Overview

14.2. Japan Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Vectibix (panitumumab) Market

15.1. Australia Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Vectibix (panitumumab) Market

16.1. South Korea Vectibix (panitumumab) Market Overview

16.2. South Korea Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Vectibix (panitumumab) Market

17.1. Western Europe Vectibix (panitumumab) Market Overview

17.2. Western Europe Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Vectibix (panitumumab) Market

18.1. UK Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Vectibix (panitumumab) Market

19.1. Germany Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Vectibix (panitumumab) Market

20.1. France Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Vectibix (panitumumab) Market

21.1. Eastern Europe Vectibix (panitumumab) Market Overview

21.2. Eastern Europe Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Vectibix (panitumumab) Market

22.1. North America Vectibix (panitumumab) Market Overview

22.2. North America Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Vectibix (panitumumab) Market

23.1. USA Vectibix (panitumumab) Market Overview

23.2. USA Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Vectibix (panitumumab) Market

24.1. Canada Vectibix (panitumumab) Market Overview

24.2. Canada Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Vectibix (panitumumab) Market

25.1. South America Vectibix (panitumumab) Market Overview

25.2. South America Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Vectibix (panitumumab) Market

26.1. Middle East Vectibix (panitumumab) Market Overview

26.2. Middle East Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Vectibix (panitumumab) Market

27.1. Africa Vectibix (panitumumab) Market Overview

27.2. Africa Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Vectibix (panitumumab) Market Regulatory and Investment Landscape

29. Vectibix (panitumumab) Market Competitive Landscape And Company Profiles

29.1. Vectibix (panitumumab) Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Vectibix (panitumumab) Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Vectibix (panitumumab) Market Company Profiles

29.3.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Vectibix (panitumumab) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Vectibix (panitumumab) Market

32. Vectibix (panitumumab) Market High Potential Countries, Segments and Strategies

32.1 Vectibix (panitumumab) Market In 2030 - Countries Offering Most New Opportunities

32.2 Vectibix (panitumumab) Market In 2030 - Segments Offering Most New Opportunities

32.3 Vectibix (panitumumab) Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Vectibix (panitumumab) Market, Overview Of Key Products - Product Examples

Table 2: Global Vectibix (panitumumab) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Vectibix (panitumumab) Market, Supply Chain Analysis

Table 4: Global Vectibix (panitumumab) Market, Major Raw Material Providers

Table 5: Global Vectibix (panitumumab) Market, Major Resource Providers

Table 6: Global Vectibix (panitumumab) Market, Major Manufacturers (Suppliers)

Table 7: Global Vectibix (panitumumab) Market, Major Distributors And Channel Partners

Table 8: Global Vectibix (panitumumab) Market, Key Technologies & Future Trends

Table 9: Global Vectibix (panitumumab) Market, Major Trends

Table 10: Global Vectibix (panitumumab) Market, Major End Users

Table 11: Global Vectibix (panitumumab) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Vectibix (panitumumab) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Vectibix (panitumumab) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Vectibix (panitumumab) Market - TAM, US$ Billion, 2025

Table 15: Global Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Vectibix (panitumumab) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Vectibix (panitumumab) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: South Korea, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Western Europe, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: UK, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Germany, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: France, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Eastern Europe, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: North America, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: USA, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Canada, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: South America, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Middle East, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Africa, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Global Vectibix (panitumumab) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 72: Global Vectibix (panitumumab) Market - Company Scoring Matrix

Table 73: Amgen Inc. Financial Performance

Table 74: Global Vectibix (panitumumab) Market, Competitive Benchmarking (In USD Billions)

Table 75: Global Vectibix (panitumumab) Market, Competitive Dashboard

Table 76: Global Vectibix (panitumumab) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 77: Global, Vectibix (panitumumab) Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Table 78: Global, Vectibix (panitumumab) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 79: Global, Vectibix (panitumumab) Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Vectibix (panitumumab) Market, Overview Of Key Products - Product Examples

Figure 2: Global Vectibix (panitumumab) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Vectibix (panitumumab) Market, Supply Chain Analysis

Figure 4: Global Vectibix (panitumumab) Market, Major Raw Material Providers

Figure 5: Global Vectibix (panitumumab) Market, Major Resource Providers

Figure 6: Global Vectibix (panitumumab) Market, Major Manufacturers (Suppliers)

Figure 7: Global Vectibix (panitumumab) Market, Major Distributors And Channel Partners

Figure 8: Global Vectibix (panitumumab) Market, Key Technologies & Future Trends

Figure 9: Global Vectibix (panitumumab) Market, Major Trends

Figure 10: Global Vectibix (panitumumab) Market, Major End Users

Figure 11: Global Vectibix (panitumumab) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Vectibix (panitumumab) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Vectibix (panitumumab) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Vectibix (panitumumab) Market - TAM, US$ Billion, 2025

Figure 15: Global Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Vectibix (panitumumab) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Vectibix (panitumumab) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: South Korea, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Western Europe, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: UK, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Germany, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: France, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Eastern Europe, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: North America, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: USA, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Canada, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: South America, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Middle East, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Africa, Vectibix (panitumumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Vectibix (panitumumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Vectibix (panitumumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Global Vectibix (panitumumab) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 72: Global Vectibix (panitumumab) Market - Company Scoring Matrix

Figure 73: Amgen Inc. Financial Performance

Figure 74: Global Vectibix (panitumumab) Market, Competitive Benchmarking (In USD Billions)

Figure 75: Global Vectibix (panitumumab) Market, Competitive Dashboard

Figure 76: Global Vectibix (panitumumab) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 77: Global, Vectibix (panitumumab) Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Figure 78: Global, Vectibix (panitumumab) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 79: Global, Vectibix (panitumumab) Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Rheumatology Therapeutics Market Report 2026 - Global Outlook – By Drug Class (Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes), By Dist...

Rheumatoid Arthritis Drugs Market Report 2026 - Global Outlook – By Drug Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Response Modifiers (...

Immune Health Supplements Market Report 2026 - Global Outlook – By Ingredients Type (Vitamins, Minerals, Herbal Botanical Extracts, Probiotics, Amino Acids, Omega 3 - Fatty Acids), By Form (Soft Gels Or Capsules, Tablets...

Denosumab Market Report 2026 - Global Outlook – By Drug Classification (Prolia, Xgeva), By Type (60 mg, 120 mg), By End-Users (Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centers) – Market Size, Trends, S...

Bevacizumab Biosimilars Market Report 2026 - Global Outlook – By Product (Avastin, Mvasi, Zirabev, Aybintio, Other Products), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distributi...

Biologic & Biosimilar RA Drugs Market Report 2026 - Global Outlook – By Source (Microbial, Mammalian, Other Sources), By Manufacturing (Outsourced, In-House), By Distribution Channel (Hospital Pharmacies, Retail Pharmaci...

Rheumatoid Arthritis Drugs Market Report 2026 - Global Outlook – By Drug Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Response Modifiers (...

Frequently Asked Questions

How big is the Vectibix (panitumumab) Market?

The Vectibix (panitumumab) market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Vectibix (panitumumab) market growth?

The global Vectibix (panitumumab) market is expected to grow at a CAGR of 7.7% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Vectibix (panitumumab) market?

Some Key Players in the Vectibix (panitumumab) market Include, Amgen Inc. .

What is the anticipated growth trend for the Vectibix (panitumumab) market?

Major trend in this market includes: Advancements In Molecular Diagnostics With Companion Diagnostic Kits Enhancing Personalized Treatment In The Vectibix (Panitumumab) Market. For further insights on this market. request a sample here

Which region has the most growth potential in the Vectibix (panitumumab) market?

North America was the largest region in the vectibix (panitumumab) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vectibix (panitumumab) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.